Skin sparing in intensity-modulated radiation therapy of nasopharyngeal carcinoma

被引:2
作者
Baba, Misba Hamid [1 ,2 ]
Singh, Benoy K. [1 ]
Wani, Shaq ul Qamar [3 ]
机构
[1] GLA Univ, Inst Appl Sci & Humanities, Dept Phys, Mathura, Uttar Pradesh, India
[2] Sherikashmir Inst Med Sci, Dept Radiol Phys & Bioengn, Srinagar, Jammu & Kashmir, India
[3] Sherikashmir Inst Med Sci, Dept Radiat Oncol, Srinagar, Jammu & Kashmir, India
关键词
Nasopharyngeal carcinoma; organ at risk; simultaneously instantaneous boost; skin sparing; RADIOTHERAPY; CHEMORADIOTHERAPY;
D O I
10.4103/jmp.jmp_27_22
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Background and Purpose: Radiation therapy of nasopharyngeal carcinomas (NPCs) involves high doses to the target structures which are superficial to the skin surfaces. As a result, the skin toxicities involved are higher and sometimes worsens to such an extent that radiotherapy needs to be interrupted unplanned. This leads to a break in radiation therapy which overall affects the local control and cure rates. The aim of this study is to decrease the skin dose by contouring skin as an organ at risk (OAR) to include in inverse planning calculation. Materials and Methods: Seventy-three cases of nasopharyngeal cancers were planned for 60 Gy to intermediate-risk planning target volume (PTVIntermediate) and 70 Gy to high risk (PTVHigh), by three different modes of Intensity-modulated radiation therapy (IMRT)- namely conventional sequential intensity-modulated radiation therapy (S-IMRT PH-I and PH-II), Skin Spared sequential intensity-modulated radiation therapy (SS-IMRT PH-I and PH-II), and Skin Spared simultaneously instantaneous boost intensity-modulated radiation therapy (SS-SIB IMRT). The plans were compared by dose volume histograms and dose statistics to the PTV as well as to the OAR's. For PTV, mean dose (Dmean), maximum dose (Dmax), and minimum dose (Dmin) were compared to check the homogeneity index (HI) while sparing the skin. For other OAR's Dmean, Dmax and dose to to 1 cubic cm was used for comparison. The skin doses to various volumes from volume to receive 5 Gy (V5) to volume to receive 70 Gy (V70) were evaluated and compared between the three techniques. Statistical analysis was done using one away ANOVA on the data editor SPSS Version 26.0 (SPSS Inc., Chicago, Illinois, USA) to evaluate the results. Continuous variables were expressed as mean +/- standard deviation, and categorical variables were summarized as frequencies and percentages. Survival analysis was done by Kaplan-Meier Estimator. Results: When the skin was considered as an OAR, the skin volume to receive 5, 10, 15, 20, 30, 40, 50, 60, 70 Gy was reduced by 6.5%, 6.5%, 6%, 11.5%, 7%, 6%, 6%, 5%, 2%, respectively, by SS-IMRT PH-I and II and 2%, 4.05%, 4%, 7%, 5%, 3%, 6%, 5%, 1%, respectively, by SS-SIB IMRT when both the SS techniques were compared with S-IMRT PH-I and II. Volume of skin to receive 20 Gy showed maximum reduction in SS-IMRT PH-I and II. A one-way ANOVA was carried out to find the differences in the skin doses between the three techniques. The skin dose in the two SS techniques, i.e., SS-IMRT PH-I and PH-II and SS-SIB IMRT was found significantly lower than that of IMRT plans without skin as an OAR, i.e., S-IMRT PH-I and PH-II (P = 0.000). The PTV doses were well within the 95%-107% of the prescribed dose (HI) and there were no significant differences in the means of the prescribed dose between the simple and skin spared IMRT techniques. The other OARs doses were also evaluated and there were no significant differences between the means of the doses among the techniques. Conclusions: SS IMRT for NPC has demonstrated reduction in skin dose while using skin as an OAR in the optimization. Moreover, decreased skin dose can decrease the skin related toxicities provided there is no compromise on Target dose coverage and OAR dose. We recommend that skin should be contoured as an OAR for NPC, provided PTV is minimally 3-5 mm beneath skin surface, in order to have a better disease control with lesser toxicities and less unplanned treatment interruptions.
引用
收藏
页码:243 / 249
页数:7
相关论文
共 50 条
  • [41] Celecoxib combined with hippocampus sparing intensity-modulated radiation therapy reduces the injury of cognitive function induced by radiotherapy in patients with nasopharyngeal carcinoma
    Fan, Qiang
    Bao, Erwen
    Zhou, Jialiang
    Tian, Ye
    Zhang, Fuzheng
    Zhao, Difei
    Wu, Jia
    Zou, Qinzhou
    Zhao, Yutian
    Che, Jun
    [J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2017, 10 (08): : 12546 - 12552
  • [42] Factors influencing the incidence of sinusitis in nasopharyngeal carcinoma patients after intensity-modulated radiation therapy
    Yan-xia Su
    Lan-ping Liu
    Lei Li
    Xu Li
    Xiu-juan Cao
    Wei Dong
    Xin-hua Yang
    Jin Xu
    Shui Yu
    Jun-fang Hao
    [J]. European Archives of Oto-Rhino-Laryngology, 2014, 271 : 3195 - 3201
  • [43] Machine learning model for predicting recurrence following intensity-modulated radiation therapy in nasopharyngeal carcinoma
    Mi Wang
    Qingxiu Yao
    Weiliu Zhu
    Nianci Xiao
    Libo Dai
    [J]. World Journal of Surgical Oncology, 23 (1)
  • [44] The Impact of Reduced-Volume, Intensity-Modulated Radiation Therapy on Disease Control in Nasopharyngeal Carcinoma
    Lin, Yu-Wei
    Chen, Chia-Chun
    Lin, Li-Ching
    Lee, Steve P.
    [J]. PLOS ONE, 2015, 10 (04):
  • [45] Effectiveness and Toxicities of Intensity-Modulated Radiation Therapy for Patients with T4 Nasopharyngeal Carcinoma
    Kong, Fang-fang
    Ying, Hongmei
    Du, Cheng-run
    Huang, Shuang
    Zhou, Jun-jun
    Hu, Chao-su
    [J]. PLOS ONE, 2014, 9 (03):
  • [46] Definitive intensity-modulated radiation therapy for nasopharyngeal carcinoma: long-term outcome of a multicenter prospective study
    Wang, Rensheng
    Wu, Fang
    Lu, Heming
    Wei, Bo
    Feng, Guosheng
    Li, Guisheng
    Liu, Meilian
    Yan, Haolin
    Zhu, Jinxian
    Zhang, Yong
    Hu, Kai
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2013, 139 (01) : 139 - 145
  • [47] Dose escalation via brachytherapy boost for nasopharyngeal carcinoma in the era of intensity-modulated radiation therapy and combined chemotherapy
    Chao, Hsing-Lung
    Liu, Shao-Cheng
    Tsao, Chih-Cheng
    Lin, Kuen-Tze
    Lee, Steve P.
    Lo, Cheng-Hsiang
    Huang, Wen-Yen
    Liu, Ming-Yueh
    Jen, Yee-Min
    Lin, Chun-Shu
    [J]. JOURNAL OF RADIATION RESEARCH, 2017, 58 (05) : 654 - 660
  • [48] Dosimetric Predictors of Hypothyroidism After Radical Intensity-modulated Radiation Therapy for Non-metastatic Nasopharyngeal Carcinoma
    Lee, V.
    Chan, Sum-Yin
    Choi, Cheuk-Wai
    Kwong, D.
    Lam, Ka-On
    Tong, Chi-Chung
    Sze, Chun-Kin
    Ng, S.
    Leung, To-Wai
    Lee, A.
    [J]. CLINICAL ONCOLOGY, 2016, 28 (08) : E52 - E60
  • [49] Dosimetry study of nasopharyngeal carcinoma based on Halcyon accelerator fixed-field intensity-modulated radiation therapy
    Li, Kuo
    Li, Chengqiang
    Zhu, Ting
    Chen, Jinhu
    Cao, Wentao
    Yin, Yong
    Ma, Changsheng
    [J]. JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2021, 17 (05) : 1165 - 1171
  • [50] Dosimetric Parameters Related to Acute Radiation Dermatitis of Patients with Nasopharyngeal Carcinoma Treated by Intensity-Modulated Proton Therapy
    Fang, Ko-Chun
    Huang, Tai-Lin
    Liao, Kuan-Cho
    Lee, Tsair-Fwu
    Hsieh, Yang-Wei
    Tsai, Wen-Ling
    Fang, Fu-Min
    [J]. JOURNAL OF PERSONALIZED MEDICINE, 2022, 12 (07):